tradingkey.logo
tradingkey.logo
検索

Stereotaxis Inc

STXS
ウォッチリストに追加
1.790USD
+0.020+1.13%
終値 07/02, 13:00ET15分遅れの株価
174.50M時価総額
損失額直近12ヶ月PER

詳細情報 Stereotaxis Inc 企業名

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Incの企業情報

企業コードSTXS
会社名Stereotaxis Inc
上場日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)
従業員数139
証券種類Ordinary Share
決算期末Aug 12
本社所在地710 N Tucker Blvd
都市ST. LOUIS
証券取引所NASDAQ OMX – NASDAQ Basic Amex
United States of America
郵便番号63101
電話番号13146786100
ウェブサイトhttps://www.stereotaxis.com/
企業コードSTXS
上場日Aug 12, 2004
最高経営責任者「CEO」Fischel (David Leo)

Stereotaxis Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

よくある質問

Stereotaxis Incの上位5名の株主は誰ですか?

Stereotaxis Incの上位5名の株主は以下のとおりです。Mr. David W. Benfer

Stereotaxis Inc(STXS)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Stereotaxis Incの株式を保有している機関は205社あり、保有株式の総市場価値は約49.70Mで、全体の50.99%を占めています。2025Q4と比較して、機関の持ち株は2238158.00増加しています。